Budapesti Uzsoki Utcai Korhaz

The Budapesti Uzsoki Utcai Korhaz is running a broad portfolio in neoplasms, with a strong focus on breast cancer across early, locally advanced, metastatic, and HER2-defined disease. These studies are designed to test new treatment approaches, improve disease control, and refine options for patients whose cancer has progressed after standard therapy.

• Hormone receptor-positive and HER2-negative breast cancer, including high-risk early disease
• HER2-positive, HER2-low, and triple-negative breast cancer
• Advanced and metastatic breast cancer with mutation-guided treatment strategies
• Trials evaluating new targeted therapies, immunotherapy combinations, and adjuvant treatment approaches

This research also includes studies aimed at improving outcomes after surgery and in advanced settings, with an emphasis on better long-term control and more personalized treatment selection.

Cardiovascular research at this site covers cardiovascular diseases and nutritional and metabolic diseases, especially atherosclerotic cardiovascular disease, heart failure, and related high-risk conditions. The trials are focused on preventing major cardiac events, easing symptoms, and improving survival and quality of life in people with established heart disease or elevated risk.

• Primary and secondary prevention of cardiovascular events
• Heart failure, including worsening and acute presentations
• Refractory angina and non-ischemic cardiomyopathy
• Studies of lipid-lowering, symptom relief, and cardiovascular outcome improvement

Several projects also explore new ways to reduce hospitalizations and support patients with obesity-related heart failure, reflecting the site’s active role in practical cardiovascular research.

Research in male urogenital diseases is centered on prostate cancer and urothelial cancer, including recurrent, metastatic, and treatment-resistant disease. The goal of these trials is to improve disease control, delay progression, and identify better treatment combinations for men with advanced cancer.

• Biochemically recurrent and high-risk recurrent prostate cancer
• Metastatic castration-sensitive and castration-resistant prostate cancer
• Unresectable locally advanced or metastatic urothelial cancer
• Studies testing hormone-based, targeted, and immunotherapy-based approaches

At Budapesti Uzsoki Utcai Korhaz, these studies reflect a strong interest in precision treatment for advanced urologic cancers.

The site also conducts studies in respiratory tract diseases and additional solid tumors, including non-small cell lung cancer, head and neck cancer, and gastric cancer. These trials are aimed at evaluating new therapies, especially for cancers with specific molecular features or those that have returned after earlier treatment.

• Advanced and metastatic non-small cell lung cancer, including KRAS G12C- and HER2-driven disease
• Unresectable, recurrent, and metastatic head and neck squamous cell carcinoma
• HER2-positive gastric and gastroesophageal junction cancer
• Studies of targeted agents, immunotherapy, and combination regimens

This area highlights the hospital’s interest in more tailored cancer care for difficult-to-treat solid tumors.

Within nervous system diseases, the site is active in multiple sclerosis and migraine research. These studies are intended to slow disability progression, support symptom prevention, and improve everyday functioning for people living with chronic neurologic conditions.

• Relapsing and progressive forms of multiple sclerosis
• Non-relapsing secondary progressive multiple sclerosis
• Menstrual migraine prevention
• Trials assessing new therapies for long-term disease control and symptom reduction

The research portfolio includes both treatment-focused and supportive approaches, showing a practical interest in managing long-term neurologic disease burden.

Smaller but important parts of the portfolio address bacterial infections and mycoses and respiratory tract diseases, along with infection prevention in surgical care. These studies are aimed at reducing complications, preventing post-operative infections, and improving outcomes in patients with chronic airway disease.

• Prevention of post-operative incisional infection
• Non-cystic fibrosis bronchiectasis
• Supportive anti-infective and respiratory symptom research
• Trials evaluating new preventive and treatment strategies in routine hospital care

These projects add a clinically useful preventive dimension to the research activity at the hospital.

Research in hormonal diseases and nutritional and metabolic diseases includes symptom-focused studies that affect quality of life as well as broader cardiometabolic risk. The main emphasis is on improving treatment tolerance and supporting patients with hormone-related side effects or obesity-associated disease.

• Moderate to severe vasomotor symptoms in women receiving endocrine therapy
• Obesity-related cardiovascular and heart failure studies
• Trials exploring metabolic and symptom benefits alongside disease treatment
• Supportive care research linked to cancer and cardiovascular management

These studies show how the site combines disease treatment with practical symptom relief and risk reduction.

The overall trial landscape at Budapesti Uzsoki Utcai Korhaz spans multiple chronic disease areas, including cardiovascular diseases, neoplasms, nervous system diseases, and respiratory tract diseases. Across these fields, the trials are mainly designed to test new therapies, compare them with standard care, and improve outcomes in patients with complex or advanced illness.

• Studies in advanced cancer, cardiovascular risk, and chronic neurologic disease
• Research focused on better disease control and longer-term outcomes
• Evaluation of targeted treatments, immunotherapy, and preventive strategies
• Broad involvement from multiple investigators across the hospital

The site’s research profile reflects a balanced mix of oncology, cardiology, neurology, and supportive care studies.